Presentations and Publications


2017 CommNETs members NET publications

Click here for: “Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance ” Theranostics 7(5): 1149-1158.

Click here for: Chan, D. L. H., et al. (2017). “Prognostic and predictive biomarkers in neuroendocrine tumours.” Crit Rev Oncol Hematol 113: 268-282.


 

2018 Presentations

VCCC Survivorship Conference February 8th – 9th | Melbourne, VIC, Australia

Poster Presented by Commonwealth Neuroendocrine Tumour Collaboration (CommNETS) PRRT Working Group

The challenges of designing and implementing a structured, international multicentre audit on quality of life (QOL) and markers of response in patients with neuroendocrine neoplasms (NEN) treated with peptide receptor radionuclide therapy (PRRT). Poster presented: Click here


2017 Presentations

Australian Gastro Intestinal Trials Group 19th Annual Scientific Meeting
October 4th – 6th | Cairns, QLD, Australia

Abstracts accepted

Follow-up and recurrence in resected gastroenteropancreatic neuroendocrine tumours: A population-based study: Click here

Optimising followup after complete surgical resection of Gastrointestinal Neuroendocrine Tumours- a Delphi process to produce expert consensus in an area lacking clinical evidence: Optimising followup after complete surgical resection of Gastrointestinal Neuroendocrine Tumours: Click here


European Society for Medical Oncology 2017 Congress
September 8th-12th | Madrid, Spain

Posters accepted

Follow-up and recurrence in resected gastroenteropancreatic neuroendocrine tumours: A population-based study: click here

Follow up recommendations for completely resected Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETs): Consensus Guidelines from the Commonwealth Neuroendocrine Tumour Collaboration (CommNETS) in conjunction with the North American Neuroendocrine Tumour Society (NANETS): click here


European Neuroendocrine Tumor Society Conference
March 8th-10th | Barcelona, Spain

Poster presented

Escalated dose somatostatin analogues (SSAs) in management of NETs: click here

Development of follow up recommendations for completely resected Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETS): Practice Survey of Commonwealth Neuroendocrine Tumour Collaboration (CommNETS) in conjunction with North American Neuroendocrine Tumour Society (NANETS) click here


American Society of Clinical Oncology Meeting
January 19th – 21st | San Francisco, USA

Oral presentation

Development of follow up recommendations for completely resected Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETS): Practice Survey of Commonwealth Neuroendocrine Tumour Collaboration (CommNETS) in conjunction with North American Neuroendocrine Tumour Society (NANETS) click here


2016 Presentations

European Society for Medical Oncology Asia Congress
December 16th-19th | Singapore, Malaysia

Posters presented

Survey of current practice regarding Functional Imaging (FI) and Peptide Receptor Redionuclide Therapy (PRRT) within the CommNETS Collaboration Click here

Optimal Follow-up strategy for resected neuroendocrine tumours: A systematic review Click here


North American Neuroendocrine Tumor Society Symposium
September 30th-October 1st | Jackson Hole, Wyoming, USA

There was an excellent CommNETs representation through both poster and oral abstract presenters.

Escalated Dose Somatostatin Analogues (SSA) in Management of NETs: A Systemic Review Click here

Everolimus for Advanced, Progressive, Nonfunctional Neuroendocrine Tumors (NET) of the Gastrointestinal (GI) Tract: Efficacy and Safety from a RADIANT-4 Subgroup Analysis Click here

Association of Disease Progression, Health-related Quality of Life (HRQoL), and Utility in Patients with Advanced, Nonfunctional, Well-differentiated Gastrointestinal (GI) or Lung Neuroendocrine Tumors (NET in the Phase 3 RADIANT-4 Trial Click here

Identifying and prioritising Gaps in Neuroendocrine Tumour Research-results of the Delphi consensus project of the Commonwealth Neuroendocrine Tumour Research Collaboration (CommNETS)  Click here


Australian Gastro Intestinal Trials Group 18th  Annual Scientific Meeting
September 14th-16th | Melbourne, VIC, Australia

Posters presented

CommNETS survey of current local practices towards Peptide Receptor Radionuclide Therapy (PRRT) and Functional Imaging (FI) for Neuroendocrine Tumours (NETs) Click here

Optimal Follow-up strategy for resected neuroendocrine tumours: A systematic review Click here


European Neuroendocrine Tumor Society 13th Annual Conference
March 9th-11th | Barcelona, Spain

Three CommNETS Abstracts were presented as posters

Current trials in Neuroendocrine Tumours: A systematic review Click here

Identifying and prioritising Gaps in Neuroendocrine Tumour Research-results of the Delphi consensus project of the Commonwealth Neuroendocrine Tumour Research Collaboration (CommNETS) Click here

CommNETS: Formation of an International Commonwealth countries NET partnership Click here